IMUX
Immunic, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.11
+2.74%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-87.4%
Return on equity
-70.1%
Return on assets
-92.0%
Return on invested capital
0.00x
Asset turnover
-$87.7M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026